Literature DB >> 19277422

Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene.

Irene Corrales1, Lorena Ramírez, Carme Altisent, Rafael Parra, Francisco Vidal.   

Abstract

Molecular diagnosis of von Willebrand Disease (VWD) is particularly complex. The autosomal von Willebrand factor gene (VWF) is large and highly polymorphic, and there is a highly homologous (>96%) partial pseudogene in chromosome 22. Because of these difficulties, application of molecular study of VWD to the clinical routine has been considerably delayed. Recent advances in sequencing technology and bioinformatics could convert direct sequencing of the complete VWF into a routine diagnostic tool for VWD, which is especially desirable in types 1 and 3. This study describes a highly optimized procedure in which all the coding and intronic flanking regions of VWF are amplified under identical thermocycling parameters in a ready-to-use PCR plate format. The entire sequencing procedure, from blood extraction to mutation identification, can be done within 24 hours, resulting in a simple, versatile, cost-effective strategy with little hands-on time requirements. To validate the method, we performed full-length VWF sequencing of 21 index cases including seven of each VWD type. A total of 30 VWF genetic variations were identified. Twelve of these sequence variations are new, including four missense, one nonsense, one insertion, the first insertion-deletion described in VWF, and 5 potential splice site mutations. To our knowledge, this is the fastest and most efficient protocol designed to date for complete sequencing of the VWF coding region in the molecular diagnosis of VWD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277422     DOI: 10.1160/th08-08-0500

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Integration of molecular and clinical data of 40 unrelated von Willebrand Disease families in a Spanish locus-specific mutation database: first release including 58 mutations.

Authors:  Irene Corrales; Lorena Ramírez; Júlia Ayats; Carme Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

2.  High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods.

Authors:  Irene Corrales; Susana Catarino; Júlia Ayats; David Arteta; Carmen Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

3.  Variable bleeding phenotype in an Amish pedigree with von Willebrand disease.

Authors:  Sweta Gupta; Meadow Heiman; Natalie Duncan; Jesse Hinckley; Jorge Di Paola; Amy D Shapiro
Journal:  Am J Hematol       Date:  2016-08-22       Impact factor: 10.047

4.  Molecular and clinical profile of type 2 von Willebrand disease in Iran: a thirteen-year experience.

Authors:  Maryam Rassoulzadegan; Fereydoun Ala; Mohammad Jazebi; Mohammad Said Enayat; Shadi Tabibian; Mahmood Shams; Mehran Bahraini; Akbar Dorgalaleh
Journal:  Int J Hematol       Date:  2020-01-14       Impact factor: 2.490

5.  The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.

Authors:  M Bowman; A Tuttle; C Notley; C Brown; S Tinlin; M Deforest; J Leggo; V S Blanchette; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

6.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

7.  Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.

Authors:  Jing Dong; Xiaojuan Zhao; Sensen Shi; Zhenni Ma; Meng Liu; Qingyu Wu; Changgeng Ruan; Ningzheng Dong
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

8.  Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.

Authors:  Priyanka Kasatkar; Shrimati Shetty; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

9.  Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

Authors:  Luciano Baronciani; Ian Peake; Reinhard Schneppenheim; Anne Goodeve; Minoo Ahmadinejad; Zahra Badiee; Mohammad-Reza Baghaipour; Olga Benitez; Imre Bodó; Ulrich Budde; Andrea Cairo; Giancarlo Castaman; Peyman Eshghi; Jenny Goudemand; Wolf Hassenpflug; Hamid Hoorfar; Mehran Karimi; Bijan Keikhaei; Riitta Lassila; Frank W G Leebeek; Maria Fernanda Lopez Fernandez; Pier Mannuccio Mannucci; Renato Marino; Nikolas Nikšić; Florian Oyen; Cristina Santoro; Andreas Tiede; Gholamreza Toogeh; Alberto Tosetto; Marc Trossaert; Eva M K Zetterberg; Jeroen Eikenboom; Augusto B Federici; Flora Peyvandi
Journal:  Blood Adv       Date:  2021-08-10

10.  The role of exon 45 and 16 in the pathogenesis of Von Willebrand disease in Iranian Patients.

Authors:  M Nasiri; H Galehdari; M Darbouy; M Yavarian; B Keikhaee
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.